XML 36 R27.htm IDEA: XBRL DOCUMENT v3.23.1
Equity-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of Equity-Based Compensation Expense

Equity-based compensation expense is classified in the condensed consolidated statements of operations and comprehensive loss as follows:

 

 

Three Months Ended March 31,

 

 

 

2023

 

 

2022

 

 

 

(In thousands)

 

Research and development

 

$

16,931

 

 

$

10,274

 

General and administrative

 

 

10,324

 

 

 

8,217

 

Total

 

$

27,255

 

 

$

18,491

 

Summary of Restricted Stock Activity

The following table summarizes the Company’s RSU activity for the three months ended March 31, 2023:

 

 

Number of
Shares

 

 

Weighted
Average Grant
Date Fair Value
per Share

 

Unvested restricted stock units as of December 31, 2022

 

 

1,941,379

 

 

$

70.70

 

Granted

 

 

2,482,686

 

 

 

42.78

 

Vested

 

 

(342,025

)

 

 

77.89

 

Cancelled

 

 

(27,553

)

 

 

59.57

 

Unvested restricted stock units as of March 31, 2023

 

 

4,054,487

 

 

$

53.07

 

Summary of Weighted Average Assumptions Used to Compute Fair Value of Option Granted Weighted average assumptions used to apply this pricing model were as follows:

 

 

Three Months Ended March 31,

 

 

2023

 

2022

Risk-free interest rate

 

4.4%

 

1.6%

Expected life of options

 

6.0 years

 

6.0 years

Expected volatility of underlying stock

 

78.7%

 

75.9%

Expected dividend yield

 

0.0%

 

0.0%

Summary of Stock Option Activity

The following is a summary of stock option activity for the three months ended March 31, 2023:

 

 

Number of
Options

 

 

Weighted
Average
Exercise
Price per
Share

 

 

Weighted
Average
Remaining
Contractual
Term

 

 

Aggregate
Intrinsic
Value

 

 

 

 

 

 

 

 

 

(In years)

 

 

(In thousands)

 

Outstanding at December 31, 2022

 

 

5,471,675

 

 

$

49.86

 

 

 

 

 

 

 

Granted

 

 

513,605

 

 

 

40.75

 

 

 

 

 

 

 

Exercised

 

 

(48,353

)

 

 

15.61

 

 

 

 

 

 

 

Forfeited

 

 

(31,838

)

 

 

100.62

 

 

 

 

 

 

 

Outstanding at March 31, 2023

 

 

5,905,089

 

 

$

49.08

 

 

 

7.37

 

 

$

59,380

 

Exercisable at March 31, 2023

 

 

3,533,700

 

 

$

39.25

 

 

 

6.70

 

 

$

48,649

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2016 Employee Stock Purchase Plan [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Summary of Weighted Average Assumptions Used to Compute Fair Value of Option Granted

The fair value of the awards issued to employees under the 2016 Plan was estimated at the beginning of the offering period using a Black-Scholes option-pricing model with the following assumptions:

 

 

Three Months Ended March 31,

 

 

2023

 

2022

Risk-free interest rate

 

4.70%

 

0.22%

Expected term (in years)

 

0.5 years

 

0.5 years

Expected volatility of underlying stock

 

69.2%

 

63.6%

Expected dividend yield

 

0.0%

 

0.0%